Home / News / Events / Events detail
Viva Insights: PROTAC—The Technology to Break Through Non-Drug Targets
On April 1, the second Viva Live Broadcast was officially launched. Dr. Jianhua Cai, Senior Vice President of Viva Biotech, shared his insights on “Introduction of PROTAC Drug Discovery”. He introduced the research progress of PROTAC and showed the application of Viva's technology platform in fueling the PROTAC drug discovery process through case studies.
Please watch the video record of the broadcast through Tencent Video or BiliBili.
Hui Hui Yao Ka Online Forum - Drug Synthesis and Process Technology
On March 24, the 7th session of the online forum - Drug Synthesis and Process Technology was held online. The forum focused on the latest developments in process design, organic and biological synthesis, catalysis, continuous reactions and green chemistry. Dr. Jianguo Ma, Senior Vice President of Viva Biotech and CEO of Langhua Pharmaceutical, joined as one of the panelists.
The 6th SABPA Annual Frontiers in Therapeutics and Diagnostics (FTD) Forum
The 6th SABPA annual Frontiers in Therapeutics and Diagnostics (FTD) forum was held online. The forum focused on the latest developments in nucleotide-based drug therapy, artificial intelligence-assisted drug discovery, and diagnostics. It also was packed with many high caliber academic and industry leaders such as Dr. Bob Langer, and Dr. Kai-Fu Lee.
Yinghong Gao, Venture Partner of Viva BioInnovator, moderated the "RNA-based Therapeutics Breakout Session" panel. Speakers shared insights on RNA editing and Antibody-oligonucleotide Conjugates, and discussed the challenges and opportunities of cutting-edge technologies in this field.
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号
- About Us
-
CRO Services
BackCRO ServicesDiscovery Biology Services
- CDMO Services
- EFS Business
- News
- Careers
- Investor Relations
- Contact Us